NCT04585750 2026-03-12The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PMV Pharmaceuticals, IncPhase 1/2 Recruiting300 enrolled
NCT06282575 2026-02-24Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerJazz PharmaceuticalsPhase 3 Recruiting286 enrolled
NCT07023731 2026-02-19A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationArvinas Inc.Phase 1/2 Recruiting159 enrolled